Document is current
Any future updates will be listed below
-
Authors
Nakatsuka, Nathan https://orcid.org/0000-0002-5091-4914
Adler, Drew
Jiang, Longda https://orcid.org/0000-0003-4964-6497
Hartman, Austin https://orcid.org/0000-0001-7278-1852
Cheng, Evan https://orcid.org/0000-0001-9036-1245
Klann, Eric https://orcid.org/0000-0001-7379-6802
Satija, Rahul https://orcid.org/0000-0001-9448-8833
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 24 July 2025
First Online: 12 August 2025
Competing interests
: In the past three years, R.S. has received compensation from Bristol-Myers Squibb, ImmunAI, Resolve Biosciences, Nanostring, 10x Genomics, Neptune Bio, and the NYC Pandemic Response Lab. R.S. is a co-founder and equity holder of Neptune Bio. The other authors declare that they have no competing interests.
